Market Research Logo

Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review

Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using poxvirus-based technology platforms including vaccinia-fowlpox (VF)-TRICOM and modified vaccinia ankara – bavarian nordic (MVA-BN). Its pipeline products are intended for the treatment of smallpox, prostate cancer, bladder cancer, solid tumors, chronic HPV infection, marburg and ebola infections, and others. Bavarian Nordic has collaboration with US government and various institutes, to develop its product candidates for the treatment of cancer and infectious diseases. It has a presence in the US, Denmark and Germany. Bavarian Nordic is headquartered in Kvistgaard, Denmark.

Bavarian Nordic AS Key Recent Developments

May 10,2017: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer
May 04,2017: Bavarian Nordic Announces Interim Results for the First Three Months of 2017
Mar 15,2017: Bavarian Nordic Announces Annual Report 2016
Jan 17,2017: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic
Nov 09,2016: Bavarian Nordic Announces Interim Results for the First Nine Months of 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Bavarian Nordic A/S - Key Facts 5
Bavarian Nordic A/S - Key Employees 6
Bavarian Nordic A/S - Key Employee Biographies 7
Bavarian Nordic A/S - Major Products and Services 8
Bavarian Nordic A/S - History 9
Bavarian Nordic A/S - Company Statement 10
Bavarian Nordic A/S - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Bavarian Nordic A/S - Business Description 13
Bavarian Nordic A/S - SWOT Analysis 14
SWOT Analysis - Overview 14
Bavarian Nordic A/S - Strengths 14
Bavarian Nordic A/S - Weaknesses 15
Bavarian Nordic A/S - Opportunities 16
Bavarian Nordic A/S - Threats 17
Bavarian Nordic A/S - Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Bavarian Nordic A/S, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
May 10, 2017: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer 29
May 04, 2017: Bavarian Nordic Announces Interim Results for the First Three Months of 2017 30
Mar 15, 2017: Bavarian Nordic Announces Annual Report 2016 31
Jan 17, 2017: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic 32
Nov 09, 2016: Bavarian Nordic Announces Interim Results for the First Nine Months of 2016 33
Aug 17, 2016: Bavarian Nordic Announces First Half 2016 Results 34
May 13, 2016: Bavarian Nordic Announces Interim Results for the First Three Months of 2016 35
Mar 07, 2016: Bavarian Nordic Announces Annual Report 2015 36
Feb 18, 2016: Edison Issues ADR Update on Bavarian Nordic 37
Section 6 – Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Bavarian Nordic A/S, Key Facts 5
Bavarian Nordic A/S, Key Employees 6
Bavarian Nordic A/S, Key Employee Biographies 7
Bavarian Nordic A/S, Major Products and Services 8
Bavarian Nordic A/S, History 9
Bavarian Nordic A/S, Other Locations 12
Bavarian Nordic A/S, Subsidiaries 12
Bavarian Nordic A/S, Key Competitors 18
Bavarian Nordic A/S, Ratios based on current share price 19
Bavarian Nordic A/S, Annual Ratios 20
Bavarian Nordic A/S, Annual Ratios (Cont...1) 21
Bavarian Nordic A/S, Annual Ratios (Cont...2) 22
Bavarian Nordic A/S, Interim Ratios 24
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Bavarian Nordic A/S, Recent Deals Summary 28
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41
List of Figures
Bavarian Nordic A/S, Performance Chart (2012 - 2016) 23
Bavarian Nordic A/S, Ratio Charts 25
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report